The 2026 Shaffer Research Grants were awarded to Kun-Che Chang, PhD, Shruthi Karnam, PhD, Kate Keller, PhD, Naoki Kiyota, MD, PhD, Gillian McLellan, PhD, Kiyoharu Miyagishima, PhD, Kerstin Nundel, PhD ...
TORONTO and HAIFA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company ...
Add Yahoo as a preferred source to see more of our stories on Google. “The term glaucoma refers to a group of diseases that cause permanent damage to the optic nerve, which is the cable that connects ...
NurExone Biologic Inc. has reported promising preclinical results for its drug ExoPTEN, which shows potential in repairing optic nerve damage and restoring vision, particularly for conditions like ...
Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...
Charisse Brown, a 38-year-old Columbia, S.C., resident, talks about her journey with glaucoma and keratoconus, which led to vision loss in her left eye. Underinsured and not qualifying for Medicaid, ...
Glaucoma is a group of eye conditions that can lead to vision loss. Health experts are unsure of the exact cause of glaucoma. When a person has glaucoma, fluid does not properly drain out of the eye.
Without treatment, glaucoma can cause irreversible, progressive vision loss and blindness. The progression rate may depend on the type of glaucoma someone has. Glaucoma is a progressive condition that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results